Oligometastatic cancer refers to the spread of cancer from its primary location to a few other sites in the body, typically up to five spots. Common areas include the brain, bones, liver, and other parts of the lung.
This stage is significant as it’s between early-stage and widely metastatic cancer. I can proactively treat these metastatic sites to eradicate them, combining this with immunotherapy, chemotherapy, and targeted-drug treatments.
Oligoprogressive cancer occurs when most of the cancer responds well to drug treatment, but a few spots begin to grow again.
In both scenarios, I use SABR to target these limited areas. This approach aims to continue your current drug treatment for as long as possible, delaying the need to switch to other cancer-controlling options and preserving future treatment possibilities.